|
Having trouble viewing this email? View it as a Web page.
Scientists from the U.S. Centers for Disease Control and Prevention co-authored a JAMA editorial along with partners titled “Cephalosporin-Resistant Gonorrhea in North America.” The editorial sounds the alarm on the potential threat of drug resistant gonorrhea, outlines updated gonorrhea treatment guidelines, and encourage the development of new drugs to treat the common sexually transmitted infection. In the editorial, authors note that “the antibiotic pipeline is running dry: continued investment in antibiotic development is critical. Meanwhile, the gonococcus has continued to develop the capability to defeat each new antibiotic used. The threat of drug-resistant gonorrhea is increasing and has reached North America. Clinicians, drug developers, and public health professionals must act now.” The full editorial can be read online at http://jama.jamanetwork.com/article.aspx?articleid=1556135
You received this email because you are subscribed to the STD home page or the STD Treatment page on the CDC web site. If you would like to change your subscriptions, please use the links below. Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates To receive the latest news for your region, please update your profile with your country, state and zip code. Questions or problems? Please contact support@xxxxxxxxxxxxxxx.
|
||||||||||||||||||||||||||||||||||
